title: Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid.
abstract: Hepatitis B core antibodies (anti-HBc) appear very early during the course of the hepatitis B virus infection and often persist years after viral clearance. In order to characterize the immunodominant domain of the HBcAg, the human immune response against the HBV nucleocapsid (HBcAg) was analyzed by using 14 synthetic peptides. Anti-HBc antibodies were detected by an indirect enzyme-linked immunosorbent assay (ELISA) with HBc peptides. Results suggest that the anti-HBc response is heterogeneous and directed against the whole primary structure of the HBc protein. Results also indicate that the epitopes recognized by anti-HBc antibodies can vary with the stages of the disease. In most sera from patients with serological evidence of acute HBV infection, anti-HBc antibodies recognized all the HBc peptides; conversely, after the acute phase, anti-HBc antibodies recognized predominantly epitopes located within the central region of the HBc protein from residue 74 to 123. Our results suggest that the HBV core protein is made up of two antigenic regions: a major one expressing a family of immunodominant epitopes from residue 74 to 123, whereas the minor encompasses the rest of the protein. The concept of the conformational nature of the unique HBcAg determinant is discussed, suggesting numerous families of linear epitopes.
authors.affiliation: Clonatec, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Tordjeman
authors.forename: G
authors.initials: G
authors.lastname: Fontan
authors.forename: V
authors.initials: V
authors.lastname: Rabillon
authors.forename: J
authors.initials: J
authors.lastname: Martin
authors.forename: C
authors.initials: C
authors.lastname: Trepo
authors.forename: A
authors.initials: A
authors.lastname: Hoffenbach
authors.forename: K
authors.initials: K
authors.lastname: Mabrouk
authors.forename: J M
authors.initials: JM
authors.lastname: Sabatier
authors.forename: J
authors.initials: J
authors.lastname: Van Rietschoten
authors.forename: G
authors.initials: G
authors.lastname: Somme
mesh_terms: D000595:Amino Acid Sequence; D001667:Binding, Competitive; D002213:Capsid / Q000276:immunology; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000737:chemistry; D006510:Hepatitis B Antibodies / Q000097:blood; D006512:Hepatitis B Core Antigens / Q000737:chemistry / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000737:chemistry / Q000276:immunology; D006513:Hepatitis B e Antigens / Q000737:chemistry / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D016056:Immunodominant Epitopes / Q000737:chemistry*; D008969:Molecular Sequence Data; D010455:Peptides / Q000276:immunology; D011487:Protein Conformation; D011994:Recombinant Proteins; D014758:Viral Core Proteins / Q000276:immunology*; D014764:Viral Proteins / Q000276:immunology
chemical_list: D000939:Epitopes; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D016056:Immunodominant Epitopes; D010455:Peptides; D011994:Recombinant Proteins; D014758:Viral Core Proteins; D014764:Viral Proteins